Skip to main content
OpenTrials

Clinical trial condition

HER-2 Positive Breast Cancer

Explore clinical trials studying HER-2 Positive Breast Cancer. Study availability and eligibility vary by location and protocol.

19 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HER-2 Positive Breast Cancer trial results

Recruiting

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

NCT07506876

Conditions
Breast Cancer - Infiltrating Ductal Carcinoma, HER-2 Positive Breast Cancer
Locations
  • Legacy Mount Hood Medical Center Gresham, Oregon, United States
  • Legacy Good Samaritan Medical Center Portland, Oregon, United States
  • Legacy Meridian Park Medical Center Tualatin, Oregon, United States
  • Legacy Salmon Creek Medical Center Vancouver, Washington, United States
View Trial Details
Active, not recruiting

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

NCT02326974

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Tennessee Oncology/Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Active, not recruiting

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

NCT02947685

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +5 more
Locations
  • UCSF San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Baycare Healthcare (Morton Plant Mease) Clearwater, Florida, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 106 locations
View Trial Details
Active, not recruiting

Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer

NCT02568839

Conditions
Breast Diseases, Breast Neoplasms, Early-Stage Breast Carcinoma, +5 more
Locations
  • Dept. of Oncology, Örebro University Hospital Örebro, Närke, Sweden
  • Dept. of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden
  • Dept. of Oncology, Skåne University Hospital Lund, Sweden
  • Dept. of Oncology, Karolinska University Hospital Stockholm, Sweden
View Trial Details
Completed

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1

NCT01565200

Conditions
Breast Diseases, Breast Neoplasms, HER-2 Positive Breast Cancer, +4 more
Locations
  • Universitair Ziekenhuis Antwerpen (UZA) Antwerp, Edegem, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Vrije Universiteit Amsterdam (VUMC) Amsterdam, Netherlands
  • University Medical Center Groningen (UMCG) Groningen, Netherlands
View Trial Details
Completed

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

NCT02492711

Conditions
HER-2 Positive Breast Cancer, Metastatic Neoplasm, Neoplasm Metastasis, +4 more
Locations
  • Ironwood Cancer & Research Center Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Western Regional Medical Center, Inc. Goodyear, Arizona, United States
  • East Valley Hematology And Oncology Burbank, California, United States
View all 167 locations
View Trial Details
Completed

A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer

NCT02488564

Conditions
HER-2 Positive Breast Cancer
Locations
  • IRST Oncologia medica Meldola, FC, Italy
  • Oncologia Medica AOU Ferrara Ferrara, FE, Italy
  • Oncologia Medica, Policlinico di Modena Modena, MO, Italy
  • Oncologia Medica Ospedale Guglielmo da Saliceto Piacenza, PC, Italy
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

NCT02675231

Conditions
HER-2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • St Jude Medical Center Fullerton, California, United States
  • TRIO - Translational Research in Oncology-US, Inc. Los Angeles, California, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
View all 93 locations
View Trial Details

Related conditions